(c) 2024 PillSync.com

INDICATIONS & USAGE Carefully consider the potential benefits and risks of Etodolac Tablets and other treatment options before deciding to use Etodolac Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac Tablets are indicated: For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For the management of acute pain

edenbridge pharmaceuticals llc.


5 years ago OVAL PINK oval orange III

OVAL PINK oval orange III

5 years ago OVAL PINK oval orange III

oval orange III OVAL PINK

HOW SUPPLIED

ETODOLAC Tablets USP are available as: 400 mg tablets: pink, oval shaped, film-coated tablet debossed with on one side and plain on the other side. - in bottles of 100, NDC 42799-111-01 - in bottles of 500, NDC 42799-111-02 500 mg tablets: blue, oval shaped, film-coated tablet debossed with on one side and plain on the other side. - in bottles of 100, NDC 42799-112-01 - in bottles of 500, NDC 42799-112-02 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store tablets in original container until ready to use. Dispense in light-resistant container. 400mg-debossing 500mg-debossing


More pills like OVAL oval orange III

Comments












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site